Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2010 1
2012 1
2013 1
2017 1
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Different local estrogen therapies for a tailored approach to GSM.
Nappi RE, Tiranini L, Martini E, Bosoni D, Cassani C, Cucinella L. Nappi RE, et al. Climacteric. 2023 Aug;26(4):361-366. doi: 10.1080/13697137.2023.2218998. Epub 2023 Jun 15. Climacteric. 2023. PMID: 37318030 Review.
Over the years, several vaginal products including different formulations (tablets, rings, capsules, pessaries, creams, gels and ovules) and molecules (estradiol [E2], estriol [E3], promestriene, conjugated equine estrogens and estrone) have been used with superimposable t …
Over the years, several vaginal products including different formulations (tablets, rings, capsules, pessaries, creams, gels and ovules) and …
Physical energies for the management of genitourinary syndrome of menopause: An overview of a systematic review and network meta-analysis.
Sarmento ACA, de Araújo Santos Camargo JD, de Freitas CL, Medeiros KS, Costa APF, Gonçalves AK. Sarmento ACA, et al. Int J Gynaecol Obstet. 2023 Dec 16. doi: 10.1002/ijgo.15304. Online ahead of print. Int J Gynaecol Obstet. 2023. PMID: 38102987 Review.
Our network meta-analysis results showed that premarin (SMD 2.60, 95% CI 7.76-3.43), conjugated estrogens (SMD 2.13, 95% CI 1.34-2.91), carbon dioxide laser (SMD 1.71, 95% CI 1.10-2.31), promestriene (SMD 1.41, 95% CI 0.59-2.24), and vaginal lubricant (SMD 1.37, 95% CI 0.5 …
Our network meta-analysis results showed that premarin (SMD 2.60, 95% CI 7.76-3.43), conjugated estrogens (SMD 2.13, 95% CI 1.34-2.91), carb …
Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.
Pérez-López FR, Phillips N, Vieira-Baptista P, Cohen-Sacher B, Fialho SCAV, Stockdale CK. Pérez-López FR, et al. Gynecol Endocrinol. 2021 Aug;37(8):746-752. doi: 10.1080/09513590.2021.1943346. Epub 2021 Jun 25. Gynecol Endocrinol. 2021. PMID: 34169794 Review.
Beneficial options include lubricants, moisturizers, vaginal estrogens (estradiol, estriol, promestriene, conjugated estrogens), androgens, prasterone, and laser application. ...
Beneficial options include lubricants, moisturizers, vaginal estrogens (estradiol, estriol, promestriene, conjugated estrogens), andr …